The Tree Behind the Resin
Boswellia serrata is a moderate to large deciduous tree in the family Burseraceae, native to the dry, rocky hillsides of India, Pakistan, and parts of Africa and the Middle East. What makes it remarkable is not the tree itself — which is unremarkable to look at — but what happens when its bark is cut: a milky, aromatic resin oozes out, hardens into translucent tears, and becomes one of the most pharmacologically complex natural substances ever studied.
The genus Boswellia contains approximately 25 recognized species. Of these, four are considered commercially important and are collectively known as frankincense: Boswellia serrata (Indian frankincense), Boswellia sacra (Arabian frankincense, the most used in religious contexts), Boswellia carterii (Somali/East African frankincense), and Boswellia frereana (elemi frankincense from Somalia). Each species has a different chemical composition, though the boswellic acid family is common to all.
Ancient Civilizations, One Resin
Sacred Smoke and Medicinal Use
Frankincense appears in Egyptian records as a commodity of extraordinary value — burned as an offering to gods, used in embalming preparations, and mentioned in medical papyri as a treatment for conditions ranging from skin disease to throat infections. Egyptian trade expeditions to the "Land of Punt" — likely modern-day Somalia or Eritrea — were mounted specifically to obtain frankincense and myrrh.
Ayurveda Formalizes the Knowledge
Boswellia serrata, known in Sanskrit as Shallaki and in Ayurvedic tradition as Salai guggul, was extensively documented in ancient Indian medical texts including the Charaka Samhita and Sushruta Samhita. These foundational Ayurvedic works describe Shallaki for treating painful joint diseases (Amavata — analogous to rheumatoid arthritis), skin conditions, respiratory disorders, and digestive complaints. The preparation methods described — decoctions in ghee for enhanced absorption — show a sophisticated empirical understanding of bioavailability centuries before the concept had a name.
A Global Trade Commodity
The demand for frankincense was so extraordinary that it drove the creation of one of the ancient world's most significant trade networks: the Incense Road (also called the Incense Route). Caravans carrying frankincense from the Arabian Peninsula and East Africa traveled thousands of kilometers to markets in Egypt, Mesopotamia, Greece, and Rome. Frankincense was, at various points, worth more by weight than gold. The cities of Petra (in modern Jordan) and Palmyra (Syria) grew wealthy as trading hubs along this route, and its economic importance is reflected in its appearance in the New Testament as one of three gifts brought by the Magi.
Medicine, Religion, and Commerce
Greek and Roman physicians including Hippocrates, Dioscorides, and Galen documented medicinal uses of frankincense. Dioscorides' De Materia Medica — the dominant pharmacological reference for over 1,500 years — describes frankincense for wound healing, skin conditions, and as an astringent. Roman temples burned it continuously; the word "frankincense" itself derives from the Old French franc encens meaning "high-quality incense."
Preserved and Transmitted
Persian physician Ibn Sina (Avicenna), whose Canon of Medicine was used as a medical textbook in European universities until the 17th century, documented boswellia use in respiratory conditions, digestive disorders, and inflammation. The knowledge survived the fall of the Western Roman Empire through Islamic scholarship, and was reintroduced to Europe during the Crusades period, where frankincense appeared in early European apothecary preparations.
From Folk Medicine to Clinical Trials
The modern scientific investigation of boswellia began in earnest in the early 1990s. Ammon, Safayhi, and colleagues at the University of Tübingen published landmark papers identifying the specific boswellic acid sub-fractions responsible for 5-lipoxygenase inhibition, putting a molecular mechanism behind centuries of empirical use. The first standardized extract, Boswellin®, was introduced to the US market in 1991 by Sabinsa Corporation. Since then, dozens of clinical trials have been published, bioavailability-enhanced formulations developed, and the compound has attracted interest from pharmaceutical researchers for conditions ranging from OA to inflammatory bowel disease, asthma, and cancer.
Boswellia vs. Frankincense: Clarifying the Terminology
A common source of confusion: "frankincense" and "Boswellia serrata" are not the same thing. Frankincense is the resin of any Boswellia species; Boswellia serrata is the Indian species specifically studied in most modern clinical research. The resin from B. sacra — used in the Middle East and in most traditional religious contexts — has a different chemical profile and has not been the subject of nearly as many controlled trials as B. serrata.
When a supplement label says "frankincense" without specifying the species or boswellic acid content, it provides no guarantee of the compound composition studied in clinical research. Always look for Boswellia serrata, standardized to boswellic acid percentage.
An endangered legacy
The growing global demand for frankincense has put significant pressure on wild Boswellia tree populations. Boswellia trees are slow-growing, and over-tapping — cutting the bark too frequently or too deeply — weakens trees and reduces long-term resin production. Several Boswellia species are considered at-risk. Sustainable sourcing and forest management are increasingly important considerations when purchasing boswellia supplements. Look for brands with traceable supply chains.
The Modern Supplement Industry
Boswellia became part of the global supplement industry in the 1990s, initially marketed primarily for joint health. As the mechanistic science developed and clinical trials accumulated, its profile expanded. The development of enhanced-bioavailability extracts — Aflapin®, 5-Loxin®, AprèsFlex® — in the 2000s and 2010s represented a significant leap in clinical utility, allowing effective dosing at much lower milligram amounts.
Today, boswellia is found in joint health supplements, gut health formulations, sports recovery products, and anti-inflammatory blends. The global boswellia extract market is growing rapidly, driven by increasing consumer interest in research-based natural health approaches and growing dissatisfaction with the side effect profiles of long-term NSAID use.
The trajectory from sacred smoke to clinical supplement is an unusual one — most traditional remedies that enter modern pharmacological testing fail to survive scrutiny. Boswellia is a notable exception: the mechanistic basis for its traditional uses has been validated, and the clinical evidence base, while not without limitations, is among the strongest for any botanical in the inflammation space.